Monitoring Agency Report for the quarter ended 31st March 2026
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bajaj Healthcare Limited filed its Q4FY26 Monitoring Agency Report with CARE Ratings confirming proper utilization of Rs. 204.97 crore raised via preferential issue (equity shares and convertible warrants) in August-September 2024. Key development: warrant holders exercised conversion option during Q4FY26, remitting the balance Rs. 52.71 crore, resulting in allotment of 20,79,409 equity shares on March 18, 2026. Funds are deployed as: Rs. 150 crore for loan repayment (fully utilized), Rs. 3.16 crore for capital expenditure, and Rs. 17.58 crore for general corporate purposes. Rs. 31.97 crore remains unutilized in the monitoring account. No deviations from disclosed objects were reported.
The full conversion of warrants increases the company's equity base and confirms receipt of the final Rs. 52.71 crore, signaling successful completion of the preferential issue fundraising. Shareholders may see some dilution from the new equity shares allotted upon warrant conversion.